OCS Lung System

2021: Start Sales

At the end of July 2021, TransMedics began selling its OCS Lung System to provide hypothermic washing, storage and transportation of donor lungs for transplantation.

The permission received from regulators marks another milestone in the path of TransMedics, which intends to create the most complete portfolio of products for storing donor organs, capable of meeting all the clinical needs of the organ transplantation market, said TransMedics CEO Dr. Waleed Hassanein in a press release.

OCS Lung System Goes on Sale

The OCS Lung System is a portable perfusion, ventilation, and monitoring system that keeps the lungs in a near-physiological state, allowing physicians to conduct an accurate assessment of tissue viability and transplantation capability. The system uses a special OCS Lung Solution - a colorless, sterile, pyrogenic solution with a low potassium content on a colloidal basis for washing donor lungs.

According to the INSPIRE clinical study, the new TransMedics OCS Lung system on the 50% reduces the risk of developing primary 3 grade graft dysfunction, which is the most frequent and most severe clinical complication of lung transplantation, and is also considered an important predictor of other short- and long-term complications and post-transplant death.

According to the developers, the TransMedics OCS Lung system is much more efficient than the usual cooling used by transplant centers, and allowed the successful transportation of donor organs in 87% of cases rejected in cold storage centers. According to a clinical study, survival with the new system was more than 91% of patients 1 year after transplantation.^[1]

Notes